|
Li, P., Shan, J., Chen, X., Zhang, D., Su, L., Huang, X., Yu, B., Zhi, Q., Li, C., Wang, Y., Tomei, ? S., Cai, Q., Ji, J., Li, J., Chouchane, L., Yu, Y., Sun, F., Xu, Z., Liu, B. and Zhu, Z., 2015. ? Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin ? E2/interleukin-6 signaling in the tumor microenvironment.?Cell Research, 25(5), pp.588-603. ?
Liu, Q.,?Cai, J., Zheng,?Y.,?Tan,?Y.,?Wang,?Y.,?Zhang,?Z.,?Zheng,?C., Zhao,?Y.,?Liu,?C., An,?Y., ? Jiang, C., Shi, L., Kang, C. and Liu, Y., 2019.?NanoRNP Overcomes Tumor Heterogeneity in ? Cancer Treatment.?NANO LETTERS, 19(11), pp.7662-7672. ? Liu, Q., Zhao, K., Wang, C., Zhang, Z., Zheng, C., Zhao, Y., Zheng, Y., Liu, C., An, Y., Shi, L., ? Kang, C. and Liu, Y., 2018.?Multistage Delivery Nanoparticle Facilitates Efficient ? CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo.?Advanced Science, 6(1), ? p.1801423. ? Xiong, G., Liu, C., Yang, G., Feng, M., Xu, J., Zhao, F., You, L., Zhou, L., Zheng, L., Hu, Y., ? Wang, X., Zhang, T. and Zhao, Y., 2019.?Long noncoding RNA GSTM3TV2 upregulates LAT2 ? and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic ? cancer.?Journal of Hematology & Oncology, 12(1). ?
Li X, Li J, Cai Y, et al. Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer. Cancer Letters. 2018 Apr 1; 418: 211-20. Shi C, Ren L, Sun C, et al. miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients. British Journal of Cancer. 2017 Sep 26; 117: 1036-47. Xu W, Zhang Z, Zou K, et al. MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.?Cell death & disease.?2017?May 4;?8: e2761. Zhou Z, Wan J, Hou X, et al. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy. Cell death & disease.?2017?Mar;?8(3): e2658. Zhuang L, Wang X, Wang Z, et al.?MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma. Cell Death & Disease.?2017?May 18;?8: e2804. Sun H J, Zhao M X, Liu T Y, et al. Salusin-βinduces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway. Scientific Reports. 2016 Mar 23. Wang Z, Li H, Guo R, et al. Antioxidants inhibit advanced glycosylation end-product-induced apoptosis by downregulation of miR-233 in human adipose tissue-derived stem cells. Scientific Reports. 2016 Mar 11. Zhang Y, Zhou S Y, Yan H Z, et al. miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting surviving?and Bmi-1. Scientific Reports. 2016 Feb 5. Gao S, Tian H,?Guo Y, et al. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy. Acta?Biomaterialia.?2015?Oct;?25:184-93.? Li P, Shan J X, Chen X H, et al. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. Cell research. 2015; 25(5): 588-603. Liu F, Kong X, Lv L, et al. TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial–mesenchymal transition and cancer stem cell phenotypes. Cancer Letters.?2015?Apr 10;?359(2):288-98.? Liu X, Lei Q, Yu Z, et al. MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells. Oncotarget. 2015 Feb 11; 6(10): 7930-43. Liu Y, Song Z M, Deng X, et al. Chitosan-coated red fluorescent protein nanoparticle as a potential dual-functional siRNA carrier. Nanomedicine. 2015 Jul; 10(13): 2005-16. Ren R?J, Zhang Y?F, Dammer E?B,?et al. Peripheral Blood MicroRNA Expression Profiles in Alzheimer’s Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism. Molecular Neurobiology. 2015?Oct 26. Tan Y, Yin H, Zhang H, et al. Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer. Oncotarget. 2015 Mar 25; 6(19): 17391-403.
|
